The association between race and treatment regret among men with recurrent prostate cancer

Prostate Cancer and Prostatic Diseases

Volumn 18, Issue 1, 2015, Pages 38-42

  Mahal, B A ^a   Chen, M H ^b   Bennett, C L ^c   Kattan, M W ^d   Sartor, O ^e   Stein, K ^f   D'Amico, A V ^g   Nguyen, P L ^g  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NOVARTIS PHARMA AG   (Switzerland)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RECURRENCE; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNICITY; EXTERNAL BEAM RADIOTHERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATECTOMY; RACE DIFFERENCE; SEXUAL DYSFUNCTION; TREATMENT REGRET; TREATMENT RESPONSE; TREND STUDY; VERY ELDERLY; BLACK PERSON; EMOTION; PATHOLOGY; PROSTATIC NEOPLASMS; PSYCHOLOGY; TREATMENT OUTCOME; TUMOR RECURRENCE;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; EMOTIONS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; PROSTATECTOMY; PROSTATIC NEOPLASMS; TREATMENT OUTCOME;

EID: 84922632820     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/pcan.2014.42     Document Type: Article

References (36)

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014; 64: 9-29.
2. NCCN Clinical Practice Guidelines in Oncology. Prostate Cancer 2014. Available at http://www.nccn.org. Accessed 30 December 2013.
3. Resnick MJ, Koyama T, Fan KH, Albertsen PC, Goodman M, Hamilton AS et al. Long-term functional outcomes after treatment for localized prostate cancer. N Engl J Med 2013; 368: 436-445.
4. Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 2008; 358: 1250-1261.
5. Pardo Y, Guedea F, Aguilo F, Fernandez P, Macias V, Marino A et al. Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment. J Clin Oncol 2010; 28: 4687-4696.
6. Eggener SE, Scardino PT, Walsh PC, Han M, Partin AW, Trock BJ et al. Predicting 15-year prostate cancer speci fic mortality after radical prostatectomy. J Urol 2011; 185: 869-875.
7. Warde P, Mason M, Ding K, Kirkbride P, Brundage M, Cowan R et al. Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial. Lancet 2011; 378: 2104-2111.
8. Klotz L, Zhang L, Lam A, Nam R, Mamedov A, Loblaw A. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol 2010; 28: 126-131.
9. Clark JA, Wray NP, Ashton CM. Living with treatment decisions: regrets and quality of life among men treated for metastatic prostate cancer. J Clin Oncol 2001; 19: 72-80.
10. Hu JC, Kwan L, Saigal CS, Litwin MS. Regret in men treated for localized prostate cancer. J Urol 2003; 169: 2279-2283.
11. Soeyonggo T, Warde P, Fleshner N, Timilshina N, Alibhai SM. Information needs of men on androgen deprivation therapy. BJU Int 2012; 109: 1503-1509.
12. Gwede CK, Pow-Sang J, Seigne J, Heysek R, Helal M, Shade K et al. Treatment decision-making strategies and influences in patients with localized prostate carcinoma. Cancer 2005; 104: 1381-1390.
13. Davison BJ, So AI, Goldenberg SL. Quality of life, sexual function and decisional regret at 1 year after surgical treatment for localized prostate cancer. BJU Int 2007; 100: 780-785.
14. Diefenbach MA, Mohamed NE. Regret of treatment decision and its association with disease-specific quality of life following prostate cancer treatment. Cancer Invest 2007; 25: 449-457.
15. Halbert CH, Weathers B, Delmoor E, Mahler B, Coyne J, Thompson HS et al. Racial differences in medical mistrust among men diagnosed with prostate cancer. Cancer 2009; 115: 2553-2561.
16. Moore AD, Hamilton JB, Knafl GJ, Godley PA, Carpenter WR, Bensen JT et al. The influence of mistrust, racism, religious participation, and access to care on patient satisfaction for African American men: the North Carolina-Louisiana Prostate Cancer Project. J Natl Med Assoc 2013; 105: 59-68.
17. Collingwood SA, McBride RB, Leapman M, Hobbs AR, Kwon YS, Stensland KD et al. Decisional regret after robotic-assisted laparoscopic prostatectomy is higher in African American men. Urol Oncol 2014; 32: 419-425.
18. Ratcliff CG, Cohen L, Pettaway CA, Parker PA. Treatment regret and quality of life following radical prostatectomy. Support Care Cancer 2013; 21: 3337-3343.
19. Clarke-Tasker VA, Wade R. What we thought we knew: African American males' perceptions of prostate cancer and screening methods. ABNFJ 2002; 13: 56-60.
20. Lambert S, Fearing A, Bell D, Newton M. A comparative study of prostate screening health beliefs and practices between African American and Caucasian men. ABNF J 2002; 13: 61-63.
21. Woods VD, Montgomery SB, Belliard JC, Ramirez-Johnson J, Wilson CM. Culture, black men, and prostate cancer: what is reality? Cancer Control 2004; 11: 388-396.
22. Forrester-Anderson IT. Prostate cancer screening perceptions, knowledge and behaviors among African American men: focus group findings. J Health Care Poor Underserv 2005; 16 (4 Suppl A): 22-30.
23. Sartor O, McLeod DG, Halabi S, Schellhammer PF, Scardino PT, D'Amico AV et al. The COMPARE Registry: design and baseline patterns of care for men with biochemical failure after definitive treatment of localized prostate cancer. Urology 2010; 75: 623-629.
24. Befort CA, Zelefsky MJ, Scardino PT, Borrayo E, Giesler RB, Kattan MW. A measure of health-related quality of life among patients with localized prostate cancer: results from ongoing scale development. Clin Prostate Cancer 2005; 4: 100-108.
25. Arozullah AM, Yarnold PR, Bennett CL, Soltysik RC, Wolf MS, Ferreira RM et al. Development and validation of a short-form, rapid estimate of adult literacy in medicine. Med Care 2007; 45: 1026-1033.
26. Nguyen PL, Chen MH, Hoffman KE, Chen RC, Hu JC, Bennett CL et al. Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer. BJU Int 2012; 110: 201-205.
27. Stokes WA, Hendrix LH, Royce TJ, Allen IM, Godley PA, Wang AZ et al. Racial differences in time from prostate cancer diagnosis to treatment initiation: a population-based study. Cancer 2013; 119: 2486-2493.
28. Underwood W, De Monner S, Ubel P, Fagerlin A, Sanda MG, Wei JT. Racial/ethnic disparities in the treatment of localized/regional prostate cancer. J Urol 2004; 171: 1504-1507.
29. Presley CJ, Raldow AC, Cramer LD, Soulos PR, Long JB, Yu JB et al. A new approach to understanding racial disparities in prostate cancer treatment. J Geriatr Oncol 2013; 4: 1-8.
30. Ryoo JJ, Ordin DL, Antonio AL, Oishi SM, Gould MK, Asch SM et al. Patient preference and contraindications in measuring quality of care: what do administrative data miss? J Clin Oncol 2013; 31: 2716-2723.
31. Hu JC, Kwan L, Krupski TL, Anger JT, Maliski SL, Connor S et al. Determinants of treatment regret in low-income, uninsured men with prostate cancer. Urology 2008; 72: 1274-1279.
32. Schroeck FR, Krupski TL, Sun L, Albala DM, Price MM, Polascik TJ et al. Satisfaction and regret after open retropubic or robot-assisted laparoscopic radical prostatectomy. Eur Urol 2008; 54: 785-793.
33. Davis JW, Kuban DA, Lynch DF, Schellhammer PF. Quality of life after treatment for localized prostate cancer: differences based on treatment modality. J Urol 2001; 166: 947-952.
34. Feldman-Stewart D, Tong C, Siemens R, Alibhai S, Pickles T, Robinson J et al. The impact of explicit values clarification exercises in a patient decision aid emerges after the decision is actually made: evidence from a randomized controlled trial. Med Decision Making 2012; 32: 616-626.
35. Aning JJ, Wassersug RJ, Goldenberg SL. Patient preference and the impact of decision-making aids on prostate cancer treatment choices and postintervention regret. Curr Oncol 2012; 19 (Suppl 3): S37-S44.
36. Winterich JA, Grzywacz JG, Quandt SA, Clark PE, Miller DP, Acuna J et al. Men's knowledge and beliefs about prostate cancer: education, race, and screening status. Ethnic Dis 2009; 19: 199-203.